Portage, Indiana

Converge Technology Solutions Corp. Announces the Closing of Portage CyberTech Non Brokered Private Placement

Retrieved on: 
Thursday, October 14, 2021

GATINEAU, Qubec and TORONTO, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Converge Technology Solutions Corp. (Converge or the Company) (TSX: CTS) (FSE: 0ZB) (OTCQX: CTSDF) is pleased to announce that Portage CyberTech Inc. (Portage CyberTech), its recently formed cybersecurity-focused SaaS entity, has closed a non-brokered private placement.

Key Points: 
  • GATINEAU, Qubec and TORONTO, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Converge Technology Solutions Corp. (Converge or the Company) (TSX: CTS) (FSE: 0ZB) (OTCQX: CTSDF) is pleased to announce that Portage CyberTech Inc. (Portage CyberTech), its recently formed cybersecurity-focused SaaS entity, has closed a non-brokered private placement.
  • Portage CyberTech issued 43,750,000 common shares at a price of $0.80 per common share for gross proceeds to Portage of $35 million (the Private Placement).
  • Upon completion of the Private Placement, Converge owns approximately 53% of Portage CyberTech, based on a $75 million valuation following completion of the Private Placement.
  • Converge Technology Solutions Corp. is a software-enabled IT & Cloud Solutions provider focused on delivering industry-leading solutions and services.

Portage Biotech Divests Portage Pharmaceuticals Limited to Juvenescence Ltd

Retrieved on: 
Thursday, March 4, 2021

Toronto, Ontario--(Newsfile Corp. - March 4, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) (CSE: PBT.U) ("Portage" or the "Company") a clinical stage immuno-oncology company accelerating research and development to overcome immune resistance, today announced the divestment of its three legacy businesses; Portage Pharmaceuticals Limited (PPL), including subsidiaries Portage Glasgow Ltd. and EyGen Ltd, to Juvenescence Ltd., a company developing therapies to transform the way people age.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - March 4, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) (CSE: PBT.U) ("Portage" or the "Company") a clinical stage immuno-oncology company accelerating research and development to overcome immune resistance, today announced the divestment of its three legacy businesses; Portage Pharmaceuticals Limited (PPL), including subsidiaries Portage Glasgow Ltd. and EyGen Ltd, to Juvenescence Ltd., a company developing therapies to transform the way people age.
  • Dr. Ian Walters, chief executive officer of Portage, commented, "We are dedicated to the continued development of our immuno-oncology pipeline and the progression of our three products in clinical testing.
  • Within these five platforms, Portage has 10 products currently in development with multiple clinical readouts expected over the next 12-24 months.
  • Juvenescence Ltd. is a life sciences company developing therapies to modify aging - increasing human health span and longevity.

Portage Commences Trading on Nasdaq

Retrieved on: 
Thursday, February 25, 2021

Trading of ordinary shares begins under the symbol "PRTG"

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - February 25, 2021) - Portage Biotech Inc. (CSE: PBT.U) (NASDAQ: PRTG) ("Portage" or the "Company") a clinical stage immuno-oncology company accelerating research and development to overcome immune resistance, today announced the commencement of trading of its ordinary shares on the NASDAQ Capital Market ("Nasdaq") under the symbol "PRTG."
  • As one of the largest exchanges in the world, listing on Nasdaq is considered a significant corporate milestone.
  • "Listing on the Nasdaq is an important step for Portage, one that we believe will increase our visibility in the marketplace, provide opportunities for institutional investors and enhance our ability to broaden our investor base," said Dr. Ian Walters, chief executive officer of Portage.
  • Within these five platforms, Portage has 10 products currently in development with multiple clinical readouts expected over the next 12-24 months.

Portage, Ind., Transforms the Municipal Payment Experience for City Residents and Staff with New Cloud Technology

Retrieved on: 
Tuesday, December 8, 2020

This is a win-win solution for citizen experience and operational efficiency, said Nina Rivas, Clerk-Treasurer for the City of Portage.

Key Points: 
  • This is a win-win solution for citizen experience and operational efficiency, said Nina Rivas, Clerk-Treasurer for the City of Portage.
  • Were resolving an immediate need to make payments safer in a pandemic for both residents and City employees.
  • And were making long-term improvements to our payment system that will streamline revenue management for the City and promote convenience for our residents.
  • City utility bills including trash, sewer and stormwater are the first payments that will be compatible with the new technology.